newsfilter
← Latest News
GlobeNewswire·

NovaBridge Biosciences to Participate in Upcoming Investor Conferences

  • NovaBridge Biosciences (NASDAQ: NBP) announced its leadership team will attend the Jefferies Global Healthcare Conference in London on November 16, 2026, & the 9th Annual Evercore Healthcare Conference on November 30, 2026.
  • CEO Srishti Gupta will present at the Jefferies conference alongside Jeffrey Nau, President & CEO of NovaBridge's majority-owned ophthalmology subsidiary Visara.
  • At the Evercore conference, CEO Srishti Gupta will be joined by CFO Chuck Silberstein for a fireside chat & one-on-one meetings.
  • The Jefferies presentation is scheduled for 5:30 AM ET (10:30 AM GMT), while the Evercore session is set for 12:55 PM ET.
  • Webcasts of both presentations will be available on NovaBridge's website for 90 days following the events.
  • NovaBridge's portfolio includes givastomig, a Claudin 18.2 × 4-1BB bispecific antibody for gastrointestinal malignancies, & the Visara ophthalmology franchise.